Cannabinoid Wafer Pouches for Controlled Oral Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Consumers seek a discreet, manageable, and slower absorption method for cannabis administration that avoids the stigma and side effects of smoking or vaping, while overcoming the drawbacks of cannabis dips and chews, such as bad taste and harmful microorganisms.
Innovation Solution
Development of cannabinoid-infused wafers and pouches using liposomal and/or micellar cannabinoid nanoparticles, processed into wafer fragments and coated with starch, which are dispensed into pouches for oral administration, allowing cannabinoids to dissolve in saliva and be absorbed primarily in the stomach.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If cannabis dips or chews are used for oral administration, then the method avoids smoking or vaping, but the product has bad taste and harmful microorganisms
Solution Approach 1:
The patent extracts only the beneficial cannabinoids from the cannabis plant through processing, separating them from harmful microorganisms and unpleasant taste components. The final product contains purified cannabinoid infusates without the contaminants present in traditional cannabis dips or chews.
Solution Approach 2:
The patent transforms the physical and chemical parameters of cannabis through processing methods including heating, mixing with carriers, and forming into wafer structures. This changes the product from raw cannabis material with harmful properties to a processed infusate with improved safety and acceptability.
2Object-affected harmful factors
If complex manufacturing processes with cannabis extracts and plant fibers are used, then harmful microorganisms are avoided, but the product emulates the look and feel of chewing tobacco which consumers dislike
Solution Approach 1:
The patent changes the physical parameters of the final product by forming it into thin wafer structures rather than using plant fiber matrices. This fundamental shape transformation distinguishes the product from chewing tobacco while maintaining the benefits of processed cannabis extracts.
Solution Approach 2:
The patent uses composite materials consisting of cannabinoid infusates combined with edible carriers or matrices that provide structural integrity without resembling tobacco products. This creates a novel material composition that achieves both safety and aesthetic goals.
3Speed
If smoking or vaping is used for cannabis administration, then rapid absorption into the blood occurs, but stigma and side effects are associated with these methods
Solution Approach 1:
The patent introduces an intermediary oral administration route that mediates between the rapid absorption of smoking/vaping and the slower absorption of traditional oral ingestion. The cannabinoid infusates in wafer form provide controlled release that avoids lung inhalation while maintaining therapeutic effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides a discreet, safer, and longer-lasting method of cannabis administration with controlled absorption, avoiding lung inhalation and potential side effects, while maintaining therapeutic benefits without psychoactive properties.
Implementation Method 1
liposomal and/or micellar cannabinoid nanoparticles are used to form the wafer
Implementation Method 2
liposomal and/or micellar cannabinoid nanoparticles are used to form the wafer
Implementation Method 3
allowing cannabinoids to dissolve in saliva
Implementation Method 4
preparing a spray dry solution, spray drying the solution into particles
Implementation Method 5
spray drying the solution into particles
Implementation Method 6
preparing a dry wafer in a heated vacuum oven
Implementation Method 7
preparing a dry wafer in a heated vacuum oven
Data Source
AI summary
The disclosed technology includes cannabinoid oral products, and methods for making same. In some embodiments, the oral products are pouches including cannabinoid infused wafers. In some embodiments, the method of making the cannabinoid oral products includes preparing an emulsion, preparing a spray dry solution, spray drying solution into cannabinoid and carbohydrate particles, preparing a paste, preparing a wafer in a heated vacuum oven, fragmenting the wafer into cannabinoid infused wafer fragments, mixing the cannabinoid infused wafer fragments with starch, and dispensing the cannabinoid infused wafer fragments into pouches. The methods may also include labeling the oral products, for example, with a THC warning symbol.